What Boston Heart Diagnostics does

Boston Heart Diagnostics Corporation is a specialty cardiovascular diagnostics laboratory headquartered in Framingham, Massachusetts. Founded in 2007 and operating as a wholly-owned subsidiary of Eurofins Scientific, the company runs a CAP-accredited and CLIA-certified clinical lab that delivers advanced cardiovascular disease (CVD) risk assessment to U.S. healthcare providers and their patients. Its core proposition targets the diagnostic gap that roughly 50% of patients who suffer a heart attack or stroke present with normal cholesterol on routine lipid panels; Boston Heart's menu is built to characterize hidden risk beyond standard lipids through proprietary methodologies including the HDL Map® (gel electrophoresis-based apoA-I quantification across five HDL subpopulations), Cholesterol Balance® (GC/MS measurement of sterol production and absorption markers), Fatty Acid Balance™ (saturated, trans, omega-3, and omega-6 profiling), and the Polygenic Risk Map™ (Illumina array-based PRS for CVD, diabetes, dementia, and cancer). The broader portfolio includes CVMap + Metabolics as a foundational panel, the CardioCognitive Genetic Profile, the GI Balance gut microbiome test, and over 50 Dried Blood Spot Tests that enable at-home sample collection with 96% correlation to venous draws.

The go-to-market is sales-led and provider-centric: physicians and cardiologists order tests through a secure provider portal, with results delivered back through the same channel and supported by Medical Science Liaisons, on-demand webinars, and continuing medical education. Patient-facing engagement runs through the mybostonheart.com portal, the 'In Good Health' blog, and the Boston Heart Lifestyle Program, which layers personalized nutrition plans and registered-dietitian coaching on top of test results (subscription pricing such as $33.75/month for the Diabetes Prevention Program). Revenue is generated primarily through professional-services billing of insurance carriers and health plans, supplemented by self-pay options and the Patient Assistance Support Services (PASS) program that provides discounts, payment plans, and financial assistance. The company is privately held, with its last disclosed financing being a 2010 Series A led by Bain Capital Ventures ($10M), and now operates under the Eurofins corporate umbrella without independent venture backing.

Operationally, Boston Heart emphasizes clinical credibility — the Founder and Chief Medical Officer Ernst J. Schaefer, MD, also serves as Laboratory Director and is the public face of the scientific content. The 2026 partnership with the NY Center for the Prevention of Heart Disease signals ongoing clinical-channel expansion, while scaling of the Dried Blood Spot menu and continued product launches (CVMap + Metabolics, Polygenic Risk Map) demonstrate sustained investment in the diagnostic surface despite the absence of recent equity capital.

Name

Boston Heart Diagnostics

Legal name

Boston Heart Diagnostics Corporation

Website

https://bostonheartdiagnostics.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

Boston Heart Diagnostics is a CAP-accredited, CLIA-certified specialty clinical laboratory that provides advanced cardiovascular disease risk assessment and personalized nutrition and lifestyle programs to U.S. healthcare providers and their patients, operating as a subsidiary of Eurofins Scientific.

Ownership category

akta.pro rank

Product category

Cardiovascular Diagnostic Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN)

akta.pro secondary industries

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• Cardiovascular diagnostic testing
• Advanced lipid panels
• Genetic cardiovascular testing
• Clinical laboratory services
• Dried blood spot testing

Headquarters

HQ city

Framingham

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory Testing Services: Boston Heart Diagnostics generates revenue through laboratory diagnostic testing services billed to insurance carriers and health plans. The company directly bills insurance for services and also offers self-pay options including patient assistance programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Boston Heart Diagnostics operates a CAP-accredited and CLIA-certified clinical laboratory that delivers advanced cardiovascular diagnostic testing, including advanced lipid panels, genetic testing, inflammation markers, metabolics, and Dried Blood Spot testing, to healthcare providers and their patients. The company supplements test results with personalized diagnostic reports, life plans, and the Boston Heart Lifestyle Program offering tailored nutrition plans and registered dietitian coaching.

Product overview

Boston Heart Diagnostics offers a comprehensive diagnostic testing platform focused on cardiovascular disease prevention and management. The core portfolio centers on CVMap + Metabolics as the foundational test, complemented by exclusive proprietary tests including the Boston Heart HDL Map® Test, Boston Heart Cholesterol Balance® Test, and Boston Heart Fatty Acid Balance™ Test. The company provides extensive genetic testing through Polygenic Risk Map™ panels and the CardioCognitive Genetic Profile. Supporting the testing services are the Boston Heart Lifestyle Program offering personalized nutrition plans with registered dietitian coaching, and Dried Blood Spot Testing enabling over 50 tests from convenient fingertip samples. The platform also includes extensive patient and provider education resources including webinars, blog content, and medical education materials. All tests are analyzed in the company's CAP-accredited and CLIA-certified clinical laboratory.

Differentiator

Problem solved

Functional benefit

Brands

• Boston Heart HDL Map: Proprietary test quantifying HDL subpopulations using gel electrophoresis technique to assess CVD risk
• Boston Heart Cholesterol Balance
• Boston Heart Fatty Acid Balance
• Polygenic Risk Map
• CVMap
• Boston Heart Lifestyle Program
• Boston Heart Diagnostic Labs

Products and services

• CVMap + Metabolics Boston Heart's foundational comprehensive cardiovascular disease risk assessment test that augments standard lipid panels with advanced diagnostic biomarkers including lipids, Lp(a), inflammatory markers, metabolics, and Boston Heart's unique Cholesterol Balance reporting for actionable treatment strategies.
• Boston Heart HDL Map® Test Proprietary test that quantifies apoA-I protein in five HDL subpopulations using gel electrophoresis, providing deeper CVD risk understanding by separating cardioprotective larger HDL particles from higher-risk smaller HDL particles.
• Boston Heart Cholesterol Balance® Test Exclusive test measuring cholesterol production markers (lathosterol, desmosterol) and absorption markers (beta-sitosterol, campesterol, cholestanol) to guide statin and ezetimibe therapy selection for LDL-C lowering.
• Boston Heart Fatty Acid Balance™ Test Test measuring major fatty acids including saturated, trans, omega-3, and omega-6 indices for cardiovascular disease characterization and management.
• Polygenic Risk Map™ - Male Complete Genetic test using Illumina Infinium Global Screening Array technology and Polygenic Risk Score analysis to assess genetic risk for multiple health conditions including coronary artery disease, stroke, diabetes, and various cancers.
• GI Balance Test Comprehensive gut microbiome assessment using genetic sequencing to evaluate metabolic pathways, bacterial balance, cardiovascular toxin producers, short-chain fatty acid production, and vitamin production.
• CardioCognitive Genetic Profile Genetic panel analyzing seven gene loci for cardiovascular disease risk, dementia risk, cognitive decline, aspirin benefit, statin-induced myopathy risk, and blood clot formation risk including APOE, KLOTHO, MTHFR, Factor V Leiden, and Factor 2 variants.
• Boston Heart Lifestyle Program Personalized lifestyle management program offering tailored nutrition plans, registered dietitian coaching, and life plans based on test results, health history, and food preferences to improve long-term patient health, including 20-minute and 50-minute coaching sessions and a Diabetes Prevention Program.
• Dried Blood Spot Testing Convenient alternative to venous blood draws using fingertip blood samples dried onto an AdvanceDx 100 card, offering over 50 tests with 96% average correlation to liquid venous blood and accurate results at room temperature shipping.
• Apolipoprotein E (apoE) Genotype Test Genetic test identifying APOE alleles (E2, E3, E4) to aid in selection of optimal cholesterol-lowering protocols and assess CVD and dementia risk.

Quantifiable outcome

• 50% of patients who suffer a heart attack or stroke have normal cholesterol levels on routine tests
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• NY Center for the Prevention of Heart DiseaseminorStrategic or Co-development Partner · 21 May 2026The NY Center for the Prevention of Heart Disease has introduced advanced cholesterol testing services in partnership with Boston Heart Diagnostic Labs, offering detailed cardiovascular risk analysis including Apo B, LDL-Particle number, small Dense LDL, Lp(a), cardiometabolic markers, inflammatory cardiac markers, and genetic markers.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Quest Diagnostics: Quest Diagnostics is the largest US clinical reference laboratory and acquired Cleveland HeartLab, directly offering advanced cardiovascular and inflammation panels (e.g., NMR LipoProfile, CardioIQ). Comparable because it serves the same cardiologists and primary care providers with overlapping advanced lipid and inflammatory testing.
• Laboratory Corporation of America (Labcorp): Labcorp is the second-largest US clinical reference lab with a broad cardiovascular menu including LDL-P, Lp(a), ApoB, and advanced inflammation markers. Comparable because it competes directly for the same advanced cardiovascular testing volume from US providers, although via a much larger generalist footprint.
• Sonic Healthcare: Sonic Healthcare is a global medical diagnostics provider operating reference laboratories across the US, Europe, and Australia with cardiology and specialty testing services. Comparable because it provides specialty cardiovascular diagnostics within a large multinational reference-lab portfolio, similar to Eurofins/Boston Heart positioning.
• Mayo Clinic Laboratories: Mayo Clinic Laboratories is the reference laboratory arm of Mayo Clinic offering esoteric cardiovascular, metabolic, and genetic testing globally. Comparable because it provides premium specialty diagnostics for advanced CV risk assessment leveraging academic clinical authority similar to Boston Heart's physician-led positioning.

Direct peers

• ARUP Laboratories: ARUP is a nonprofit specialty reference laboratory operated by the University of Utah offering esoteric cardiovascular, lipid, and genetic testing. Comparable because it provides high-complexity specialty diagnostics for hospital systems and specialty practices using LDT-style methodology similar to Boston Heart.
• Atherotech Diagnostics Lab: Atherotech is a specialty cardiovascular diagnostics laboratory offering the VAP (Vertical Auto Profile) advanced lipid test and related CV risk markers. Directly comparable because it pioneered proprietary advanced lipid testing for cardiologists and preventive medicine physicians in the US market.
• SpectraCell Laboratories: SpectraCell is a specialty clinical laboratory offering advanced cardiovascular, metabolic, micronutrient, and inflammation testing through a provider-based model. Comparable because it targets the same functional and preventive medicine channels with proprietary specialty panels.
• Genova Diagnostics: Genova Diagnostics is a specialty clinical laboratory offering advanced cardiovascular, metabolic, gastrointestinal, and genetic testing. Comparable because it operates a similar provider-focused specialty lab model with proprietary panels and lifestyle/nutrition add-ons.
• PreventionGenetics: PreventionGenetics is a CLIA-certified clinical DNA testing laboratory offering cardiovascular genetic testing panels and PGx. Comparable because it provides genetic cardiovascular and pharmacogenomic testing using similar clinical-lab LDT methodology as Boston Heart's Polygenic Risk Map and CardioCognitive Profile.

Emerging players

• Metabolon: Metabolon provides metabolomics-based biomarker profiling services for clinical research, pharma, and advanced diagnostics including cardiovascular applications. Comparable because it operates in the metabolomics/biomarker testing space that intersects with Boston Heart's CVMap metabolics panel and TMAO testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/BostonHeartDX
• Facebookfacebook.com/BostonHeart
• LinkedInlinkedin.com/company/boston-heart-diagnostics
• Instagraminstagram.com/bostonheartdx

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Heart Diagnostics